Tecovirimat in Non-hospitalized Patients With Monkeypox
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
PLATINUM-CAN is a parallel collaborative trial linked with the sister trial PLATINUM led by
Oxford University. PLATINUM-CAN is a multi-centre, randomized, placebo-controlled trial of
Tecovirimat in non-hospitalized patients with presumptive or PCR confirmed monkeypox
infection. The study will provide evidence on the efficacy and safety of Tecovirimat for
laboratory-confirmed monkeypox in outpatients with monkeypox infection and determine the
feasibility of conducting interventional monkeypox trials in Canada.
Phase:
Phase 3
Details
Lead Sponsor:
Marina Klein
Collaborators:
CIHR Canadian HIV Trials Network McGill University Health Centre/Research Institute of the McGill University Health Centre Unity Health Toronto University Health Network, Toronto University of British Columbia